Meredith McCann


Admitted to the Ontario Bar: 2019


Meredith enjoys the fast-paced and challenging nature of securities law. When it comes to complex capital markets transactions or navigating regulatory requirements, Meredith’s primary focus is on her clients’ interests. She is dedicated to providing exceptional service, and goes the extra mile to ensure her clients’ business objectives are met.

Meredith is a member of the firm’s Capital Markets Group. Her practice focuses on corporate finance, securities law, mergers and acquisitions and general corporate and commercial matters. She also has experience assisting clients in meeting continuous disclosure requirements and corporate governance matters.

Professional Involvement


  • Canadian Bar Association
  • Ontario Bar Association

Representative Matters

Represented Energy+ Inc. in the closing of a $55 million offering of 2.968% senior unsecured debentures due August 10, 2060. The debentures were sold on an agency basis to accredited investors on a private placement basis by means of a confidential offering memorandum.

Represented MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, in its completion of a $37.8 million private placement with an institutional investor.

Represented Allied Properties Real Estate Investment Trust, a leading owner, manager and developer of distinctive urban workspace in Canada’s major cities and network-dense urban data centres in Toronto, in its completion of a $300 million debt offering of 3.131% series G senior unsecured debentures.

Represented Allied Properties Real Estate Investment Trust in its completion of a $400 million debt offering.

Represented Allied Properties Real Estate Investment Trust in its completion of a $345 million public equity offering of units.

Represented Pistil Partners Inc. in the completion of a private placement of its common shares and acquisition of Ironside Hemp Company Inc., a private U.S.-based hemp management company.

Represented MediPharm Labs Inc., a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, in the completion of a $75 million bought deal offering.


  • JD, University of Windsor, 2018
  • LLB (Exchange Program), University of Lucerne, 2017
  • BA (Honours), Ryerson University, 2015